184 related articles for article (PubMed ID: 7212899)
1. Transfer factor therapy for histoplasmosis in a patient with Hodgkin's disease.
Catanzaro A; Spitler LE; Campbell GD; Moser KM
Arch Intern Med; 1981 Mar; 141(4):533-7. PubMed ID: 7212899
[TBL] [Abstract][Full Text] [Related]
2. Aspecific transfer factor in children with Hodgkin's disease.
Pasino M; Vadalà CR; Tonini GP; Comelli A; Perutelli P
Boll Ist Sieroter Milan; 1976; 55(2):168-73. PubMed ID: 1088071
[TBL] [Abstract][Full Text] [Related]
3. Effect of transfer factor on lymphocyte function in anergic patients.
Kirkpatrick CH; Rich RR; Smith TK
J Clin Invest; 1972 Nov; 51(11):2948-58. PubMed ID: 5080419
[TBL] [Abstract][Full Text] [Related]
4. Disseminated varicella infection: treatment with transfer factor in a patient with Hodgkin's disease.
Ng RP
Scand J Infect Dis; 1977; 9(2):139-40. PubMed ID: 331459
[TBL] [Abstract][Full Text] [Related]
5. Use of transfer factor in patients with depressed cellular immunity and chronic infection.
Rocklin RE
Birth Defects Orig Artic Ser; 1975; 11(1):431-5. PubMed ID: 1096987
[TBL] [Abstract][Full Text] [Related]
6. Increase in E-rosettes after transfer factor (TF) treatment: fractionation of TF.
Khan A; Thometz D; Garrison O; Hill JM
Ann Allergy; 1976 May; 36(5):330-6. PubMed ID: 1084716
[TBL] [Abstract][Full Text] [Related]
7. Transfer factor in Hodgkin's disease: a randomized clinical and immunological study.
Hancock BW; Bruce L; Sokol RJ; Clark A
Eur J Cancer Clin Oncol; 1988 May; 24(5):929-33. PubMed ID: 3049116
[TBL] [Abstract][Full Text] [Related]
8. The in vivo effect of thymic factor (thymostimulin) administration in Hodgkin's disease patients. Correlation of skin reactivity and leukocyte migration-inhibition factor in the sera of anergic subjects.
Velardi A; Rambotti P; Cernetti C; Spinozzi F; Bertotto A; Martelli MF
Thymus; 1983 Sep; 5(5-6):429-32. PubMed ID: 6362105
[TBL] [Abstract][Full Text] [Related]
9. Cell mediated immunity in patients with Virchowian hanseniasis before and after treatment with transfer factor.
Leser PG; Margarido L; Belda W; Sartori SG; Hares WA; Freire CA; Fleury R; Montenegro MR; Leser W; Naspitz CK
Hansenol Int; 1980 Jun; 5(1):3-27. PubMed ID: 7042563
[TBL] [Abstract][Full Text] [Related]
10. Effect of dialysable leukocyte extract on the mononuclear leukocytes in Hodgkin's disease.
Lukács K; Kávai M; Berényi E; Frendl G; Schröder I; Szegedi G
Haematologia (Budap); 1985; 18(2):105-13. PubMed ID: 3161810
[TBL] [Abstract][Full Text] [Related]
11. Disseminated histoplasmosis in advanced Hodgkin's disease.
Chua WA; Krauss S; Aggio MC
J Tenn Med Assoc; 1978 Oct; 71(10):748-50. PubMed ID: 723252
[No Abstract] [Full Text] [Related]
12. Guidelines for immunotherapy of antigen-specific defects with transfer factor.
Wilson GB; Fudenberg HH; Keller RH
J Clin Lab Immunol; 1984 Feb; 13(2):51-8. PubMed ID: 6202873
[TBL] [Abstract][Full Text] [Related]
13. Cellular immunity in patients with the Wiskott-Aldrich syndrome before and after administration of transfer factor: a follow-up study.
Schut BJ; Dooren LJ; Uittenbogaart CH; Schellekens PT; Eijsvoogel VP
Immunology; 1979 Jan; 36(1):1-12. PubMed ID: 369991
[TBL] [Abstract][Full Text] [Related]
14. Cellular immunity in acne vulgaris during transfer factor treatment.
Ashorn R; Uotila A; Kuokkanen K; Räsänen L; Karhumäki E; Krohn K
Ann Clin Res; 1985; 17(4):152-5. PubMed ID: 2934019
[TBL] [Abstract][Full Text] [Related]
15. Transfer factor as an approach to the treatment of immune deficiency disease.
Schulkind ML; Ayoub EM
Birth Defects Orig Artic Ser; 1975; 11(1):436-40. PubMed ID: 1096988
[TBL] [Abstract][Full Text] [Related]
16. Immunologic features of chronic granulomatous mucocutaneous candidiasis before and after treatment with transfer factor.
Horsmanheimo M; Krohn K; Virolainen M; Blomqvist K
Arch Dermatol; 1979 Feb; 115(2):180-4. PubMed ID: 426525
[TBL] [Abstract][Full Text] [Related]
17. Transfer factor in the treatment of chronic mucocutaneous candidiasis: a controlled study.
Mobacken H; Hanson LA; Lindholm L; Ljunggren C
Acta Derm Venereol; 1980; 60(1):51-5. PubMed ID: 6153834
[TBL] [Abstract][Full Text] [Related]
18. Transfer factor in Hodgkin's disease.
Ng RP; Moran CJ; Alexopoulos CG; Bellingham AJ
Lancet; 1975 Nov; 2(7941):901-3. PubMed ID: 53376
[TBL] [Abstract][Full Text] [Related]
19. Chronic pulmonary histoplasmosis: improved lymphocyte response with transfer factor.
Smith CR; Griffin DE; Graybill JR
Ann Intern Med; 1976 Jun; 84(6):708-9. PubMed ID: 937885
[No Abstract] [Full Text] [Related]
20. Treatment with transfer factor of herpes zoster varicella infection in Hodgkin's disease.
Silvino G; Rubertelli M; Cristofolini M; Sagramoso Z; Pisciolli F; Dalri P
Haematologica; 1978 Feb; 63(1):56-60. PubMed ID: 417972
[No Abstract] [Full Text] [Related]
[Next] [New Search]
